| 000 | 01285 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517121320.0 | ||
| 264 | 0 | _c20170622 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1759-4804 | ||
| 024 | 7 |
_a10.1038/nrrheum.2016.158 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDörner, Thomas | |
| 245 | 0 | 0 |
_aBeyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. _h[electronic resource] |
| 260 |
_bNature reviews. Rheumatology _c11 2016 |
||
| 300 |
_a645-657 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _ximmunology |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Reduction Procedures _xmethods |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aLipsky, Peter E | |
| 773 | 0 |
_tNature reviews. Rheumatology _gvol. 12 _gno. 11 _gp. 645-657 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrrheum.2016.158 _zAvailable from publisher's website |
| 999 |
_c26509374 _d26509374 |
||